The field of clinical endocrinology and rare disorders encompasses a diverse range of hormonal conditions beyond common metabolic diseases. Disorders such as Addison’s disease, Cushing’s syndrome, and congenital adrenal hyperplasia require specialized diagnostic and therapeutic approaches. Advances in molecular endocrinology have improved the understanding of genetic mutations and their role in rare endocrine dysfunctions. Precision medicine, including targeted hormone replacement therapies and gene-based interventions, is transforming treatment strategies. Improved diagnostic tools, including next-generation sequencing and biomarker analysis, are enabling earlier detection and better disease management. Continued research and interdisciplinary collaboration are crucial to developing innovative therapies for rare endocrine disorders.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States